Community

Aaron B. Cowley, Ph.D.

Chief Scientific Officer, Arranta Bio

Dr. Aaron B. Cowley is the Chief Scientific Officer at Arranta Bio, having been a co-founder and the Chief Technical Officer of Captozyme, which served the microbiome CDMO market for 10 years since 2009 and merged with Arranta Bio in November 2019. He was the recipient of the prestigious Ruth L. Kirschstein National Research Service Award for his post-doctoral work at the University of Georgia. He holds a bachelor’s degree in biochemistry from Benedictine College, a Ph.D. in inorganic chemistry from the University of Kansas, and an MBA from the University of Florida.

Contributions

Community

Aaron B. Cowley, Ph.D.

Chief Scientific Officer, Arranta Bio

Contributions

Enabling the Commercialization of Microbiome Live Biotherapeutic Products with Fit-for-Purpose Cryopreservatives

Design Considerations for Live Biotherapeutic Product Facilities Working with Spore-Forming Bacteria

Framing the Narrative on CMC Development for Microbiome Therapeutics

Extensive Experience Is Crucial to Speed to the Clinic and Market for Live Biotherapeutic Products

Reflections on a 10-Year Journey in the Microbiome